Medipal Holdings×Alfresa Holdings×Hanwa×Suzuken

Different ways of making money, on the same scale.

Same yardstick

MetricMedipal HoldingsFY ending Mar 2026Alfresa HoldingsFY ending Mar 2026HanwaFY ending Mar 2026SuzukenFY ending Mar 2026
Revenue¥3.82T¥3.1T¥2.66T¥2.49T
COGS ratio93.2%93.0%94.7%92.3%
Operating margin1.4%1.2%2.2%1.5%
Net margin1.1%1.3%1.4%1.5%
FCF margin1.0%0.3%2.6%0.6%

Highlighted = best value for that metric

Compare industry percentiles by axis

Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.

  • Medipal HoldingsPrimary industry: Specialty Trading & Wholesale
  • Alfresa HoldingsPrimary industry: Specialty Trading & Wholesale
  • HanwaPrimary industry: Specialty Trading & Wholesale
  • SuzukenPrimary industry: Specialty Trading & Wholesale
CompanyRank
  • Revenue growth

    • Medipal Holdings32.7179 peers
    • Alfresa Holdings33.2179 peers
    • Hanwa77.4179 peers
    • Suzuken31179 peers
  • Profitability

    • Medipal Holdings21.4185 peers
    • Alfresa Holdings14.9185 peers
    • Hanwa37.6185 peers
    • Suzuken22.4185 peers
  • Cash conversion

    • Medipal Holdings42.2179 peers
    • Alfresa Holdings56.1179 peers
    • Hanwa67.3179 peers
    • Suzuken47.2179 peers
  • Efficiency

    • Medipal Holdings77185 peers
    • Alfresa Holdings79.2185 peers
    • Hanwa83.5185 peers
    • Suzuken81.4185 peers
  • Financial strength

    • Medipal HoldingsN/A
    • Alfresa HoldingsN/A
    • Hanwa22.520 peers
    • SuzukenN/A

Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.

Money flows side by side

Chart height is proportional to revenue.

Medipal Holdings¥3.82T · keeps ¥1 per ¥100
Alfresa Holdings¥3.1T · keeps ¥1 per ¥100
Hanwa¥2.66T · keeps ¥2 per ¥100
Suzuken¥2.49T · keeps ¥2 per ¥100

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open Markdown